Progression of Human Renal Cell Carcinoma via Inhibition of RhoA-ROCK Axis by PARG1()()

Renal cell carcinoma (RCC) is the most lethal urological malignancy with high risk of recurrence; thus, new prognostic biomarkers are needed. In this study, a new RCC antigen, PTPL1 associated RhoGAP1 (PARG1), was identified by using serological identification of recombinant cDNA expression cloning...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Junichiro, Ito, Keiichi, Fujita, Tomonobu, Matsuzaki, Yuriko, Asano, Takako, Hayakawa, Masamichi, Asano, Tomohiko, Kawakami, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284488/
https://www.ncbi.nlm.nih.gov/pubmed/28131798
http://dx.doi.org/10.1016/j.tranon.2016.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284488/
https://www.ncbi.nlm.nih.gov/pubmed/28131798
http://dx.doi.org/10.1016/j.tranon.2016.12.004

Ejemplares similares